from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0680c/-

LFCtreatmentdescriptionclass of inhibitor

0.717

Amikacinug/mL Amikacintranslation

1.235

Cap5-10ug/mL Capreomycintranslation

2.294

Rox10-50 ug/mL Roxithromycintranslation

-0.395

SM2-5 ug/mL Streptomycintranslation

0.292

Tet5-10 ug/mL Tetracyclinetranslation

-0.367

Rif0.2-5ug/mL Rifampicintranscription

-0.774

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.591

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.391

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.586

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.192

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.176

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-0.695

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.070

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.506

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.160

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.149

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.680

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.068

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.504

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.166

KCN5-20 ug/mL Potassium cyaniderespiration

-1.318

NaN30.2-2 mM Sodium aziderespiration

-0.028

Nigericin50 uM Nigericinrespiration

1.195

TRC10-150 ug/mL Triclosanrespiration

-1.283

TRZ10-25 ug/mL Thioridazinerespiration

-1.753

Valinomycin0.5-10 uM Valinomycinrespiration

0.381

ZnSO42 mM ZnSO4respiration

-0.645

menadione6-10 ug/mL Menadionerespiration

-0.053

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.438

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.058

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.362

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.134

NRP_1Non-replicating persistence stage 1dosRassociated

-0.546

Amp0.2mg/mL AmpicillincellWall

-0.650

Cephalexin20-100 ug/mL CephalexincellWall

-0.256

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.390

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.742

EMB10-20 ug/mL EthambutolcellWall

-0.836

Eta12-40 ug/mL EthionamidecellWall

-1.153

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.064

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.602

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.853

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

2.375

BZA0.12 mg/mL BenzamidearomaticAmides

2.028

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.650

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.234

H2O24 mM hydrogen peroxideDNAdamaging

-0.132

Levo10 ug/mL LevofloxacinDNAdamaging

-0.060

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.205

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.180

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.077

UVUV-irradiationDNAdamaging

-0.853

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.375

Antimycin12.5-50 ug/mL Antimycin A?

-0.244

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.250

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.641

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.221

PA8240.2-2 ug/mL PA-824?

-0.835

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.445

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.104

Verapamil50 uM Verapamil?

-0.638

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.720

methoxatin10-20 ug/mL Methoxatin?